The role of andrographolide as a potential anticancer agent against gastric cancer cell lines: a systematic review

PeerJ. 2024 Nov 20:12:e18513. doi: 10.7717/peerj.18513. eCollection 2024.

Abstract

Objective: To critically analyse literature on the anticancer properties of andrographolide in in vitro studies on gastric cancer cells.

Method: This study systematically reviewed articles from 2013 to 2024 across five prominent databases; PubMed, Google Scholar, Web of Science, Scopus, and Science Direct, EMBASE, Cochrane library and DOAJ. The study eligibility criteria include original studies assessing using gastric cancer cell lines and articles utilizing extracted andrographolide from Andrographis paniculata or standard andrographolide source treatment. The following exclusion criteria were articles written in a different language, review articles, book chapters, conference articles, scientific reports. Duplicated articles were removed using Mendeley software.

Result: Out of 93 articles, six were relevant, primarily focusing on in vitro analyses with gastric adenocarcinoma cell lines.

Conclusion: These studies indicate that andrographolide can hinder the cell cycle, suppress cell proliferation, alleviate oxidative stress, and induce apoptosis by prompting gastric cancer cells to undergo self-destruction, which is a crucial mechanism for controlling and eliminating cancerous growths.

Keywords: Andrographis paniculata; Andrographolide; Anticancer; Gastric cancer cell lines; In vitro.

Publication types

  • Systematic Review

MeSH terms

  • Andrographis / chemistry
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Apoptosis* / drug effects
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Proliferation* / drug effects
  • Diterpenes* / pharmacology
  • Diterpenes* / therapeutic use
  • Humans
  • Oxidative Stress / drug effects
  • Stomach Neoplasms* / drug therapy
  • Stomach Neoplasms* / pathology

Substances

  • Diterpenes
  • andrographolide
  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic

Grants and funding

This work was supported by the Malaysian Ministry of Higher Education for the financial support via a Fundamental Research Grant Scheme (FRGS/1/2022/SKK12/USM/03/5) for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.